Soaring ointment prices are a dermatologic mystery
The New York Times, August 10, 2012
Other than pharmacy benefit managers, which manage prescription drug plans, few other players in the health care market make decisions based on cost. When doctors write a prescription, they often fail to consider the price of the drug. And since many patients have prescription drug coverage, they also often ignore the cost. The situation can create a lucrative opening for some companies, especially in a low-profile corner of the industry like dermatology, where price increases might not attract broader notice.
Most Viewed
Most Emailed
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Patient Harm Data to Remain on Medicare's Hospital Compare Site
- Building a Better Healthcare Board
- Quiet ORs Better for Patient Safety
- Hard-Nosed About Physician Teamwork
- Case Study: Advance Care Conversations
- Tavenner Confirmed as CMS Administrator
- CMS Releases Hospital Pricing Data
- Hospital Pricing Data Dump Won't Hurt You, Yet
- Access to EHR Notes Lauded by Patients, Providers
